• 25 Sep 25
 

Melrose Industries - Appointment of Senior Independent Director


Melrose Industries PLC | MRO | 593 1.2 0.2% | Mkt Cap: 7,497m



RNS Number : 6886A
Melrose Industries PLC
25 September 2025
 

25 September 2025

Melrose Industries PLC

("Melrose" or the "Company")

Alison Goligher appointed as Senior Independent Director with effect from 1 October 2025

With effect from 1 October 2025, Alison Goligher, independent Non-executive Director and Chair of the Remuneration Committee, shall become Senior Independent Director of the Company.

Alison succeeds David Lis, who will step down from the role of Senior Independent Director with effect from 1 October. As previously announced, David completed nine years on the Board in May 2025 and was asked by the Board to extend his tenure to assist with succession planning and the continued development of a diverse Board. This has included the recent appointments of Alison and Guy Hachey as Non-executive Directors, bringing further aerospace sector and FTSE 100 experience onto the Board.

We thank David for his valuable contributions in the role of Senior Independent Director; as planned, David will continue to serve on the Board as a Non-executive Director until the end of the year.

 

Enquiries:

Investor Relations: Mat Wootton

 

+44 (0) 7483 961 233, mat.wootton@melroseplc.net

 

Media: Tom Pigott

 

+44 (0) 207 404 5959, melrose@brunswickgroup.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOALIMITMTITBIA